Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-16T17:25:25.298Z Has data issue: false hasContentIssue false

Glycopeptide Resistance in Staphylococcus haemolyticus During Treatment With Teicoplanin

Published online by Cambridge University Press:  02 January 2015

Marjolijn Blans
Affiliation:
Eijkman-Winkler Institute for Clinical Microbiology, Utrecht University, Utrecht, The Netherlands
Annet Troelstra
Affiliation:
Eijkman-Winkler Institute for Clinical Microbiology, Utrecht University, Utrecht, The Netherlands
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2001

References

1.Sieradzki, K, Villari, P, Tomasz, A. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci. Antimicrob Agents Chemother 1998;42:100107.Google Scholar
2.Sloos, JH, Klundert van de, JAM, Dijkshoorn, L, Boven van, CPA. Changing susceptibilities of coagulase-negative staphylococci to teicoplanin in a teaching hospital. J Antimicrob Chemother 1998;42:787791.CrossRefGoogle ScholarPubMed
3.Martin, E, Nouvellon, M, Pestel, M, Pons, JL, Lemeland, JF. Evaluation of the Epsilometer test (E test) for testing the susceptibility of coagulase-negative staphylococci to teicoplanin. J Antimicrob Chemother 1995;36:8391.Google Scholar
4.Aubert, G, Passot, S, Lucht, F, Dorche, G. Selection of vancomycin- and teicoplanin-resistant Staphylococcus haemolyticus during teicoplanin treatment of S epidermidis infection. J Antimicrob Chemother 1990;25:491493.CrossRefGoogle ScholarPubMed
5.Cercenado, E, Garcia-Leoni, ME, Diaz, MD, Sanchez-Carrillo, C, Catalan, P, Bernaldo de Quiros, JCl, et al. Emergence of teicoplanin-resistant coagulase-negative staphylococci. J Clin Microbiol 1996;34:17651768.Google Scholar